1Steen E, Terry BM, Rivera E J, et al. Impaired insulin and insulin like growth factor expression and signaling mechanisms in Alzheimer's disease is this type 3 diabetes[ J] ? J Alzheimer's Dis,2005 ;7 ( 1 ) :63- 80.
2Lester-Coll N, Rivera EJ, Soscia SJ, et al. Intracerebral streptozotocin model of type 3 diabetes:relevance to sporadic Alzheimer's disease[ J]. J Alzheimers Dis ,2006 ; 1 ( 1 ) : 13-33.
3Basu R, Breda E, Oberg AL,et al. Mechanisms of the age associated deterioration in glucose tolerance:contribution of alterations in insulin secretion, action, and clearance [ J]. Diabetes,2003 ;52 ( 7 ) : 1738 -45.
4Basu R, Man CD, Campioni M ,et al. Effects of age and sex on postprandi- al glucose metabolism:differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction [ J ]. Diabetes,2006 ;55 ( 7 ) : 2001-4.
6Watson GS, Peskind ER, Asthana S, et al. Insulin increases CSF Ab42 levels in normal older adults [ J). Neurology,2003 ; 60 ( 7 ) : 1899 -903.
7Zhao LX, Bruce T, Takashi M, et al. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade;implication for Alzheimer's disease intervention[ J]. J Neurosci,2004;24(10) :11120-6.
8Craft S. Insulin resistance and Alzheimer's disease pathogenesis:potential mechanisms and implications for treatment [ J]. Curr Alzheimer Res, 2007; 4(1) :147-52.
9Skeberdis VA, Lan J, Zhang X, et al. Insulin promotes rapid delivery of N-methyl-D-asparate receptors to the cell surpace by exocytosis[J]. Proc Natl Acad Sci USA, 1998 ;3561-6.
10Byrne JH. Learning and memory: basic mechanisms. In: Squire LR,Bloom FE, McConnell SK, et al. eds. Fundamental neuroscience[ M]. San Diego CA : Academic Press ,2003 : 1276-98.
2Park CR. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev, 2001, 25:311-323.
3Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci, 1998,112 : 1199-1208.
4Zhao WQ,Chen H, Xu H, et al. Brain insulin receptors and special memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem, 1999,274:34893-34902.
5Craft S, Asthana S, Newcomer JW, et al. Enhancement of memory in Alzheimer disease with insulin somatostatin, but not glucose. Arch Gen Psychiat,1999,56 : 1135-1140.
6Watson GS, Peskind ER, Asthana S, et al. Insulin increases CSF Ab42 levels in normal older adults. Neurology, 2003,60 : 1899-1903.
7Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). J Neural Transm, 2002,109 : 991-1002.
8Zhao LX, Bruce T, Takashi M, et al. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. J Neurosci, 2004, 24:11120-11126.
9Gispen W H, Biessels GJ. Cognitive and synaptic plasticity in diabetes mellitus. Trends Neurosci, 2000,23:542 549.
10Skeberdis VA, Lan J, Zheng X, et al. Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surpace by exocytosis. Proc Natl Acad Sci USA,1998,3561-3566.
4Vuong C, Van Uum SH, O'Dell LE, et al. The effects of opioids and opioid analogs on animal and human endocrine systems[J]. Endocrine Reviews, 2010, 31 ( 1 ) :98 - 132.
6Minami M, Toya T, Katao Y, et al. Cloning and expression of a cDNA for the rat kappa-opioid receptor [J]. FEBS Lett, 1993, 329 (3) :291 -295.
7Xie GX, Meng F, Mansour A, et al. Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor [J]. Proc Natl Acad Sci U S A, 1994, 91 (9) :3779 -3783.
8Yamaotsu N, Hirono S. 3D-Pharmacophore identification for k-Opioid agonists using ligand-based drug-design techniques [ J ]. Top Curr Chem, 2011, 299:277 - 307.
9Rasakham K, Liu-Chen LY. Sex differences in kappa opioid pharmacology[J]. Life Sciences, 2011, 88( 1 -2) :2 - 16.
10Schwarzer C. 30 years of dynorphins-New insights on their functions in neuropsychiatric diseases[J]. Pharmacol Ther, 2009, 123 (3) :353 -370.
